14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
AMD vs VIVS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 19, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over VivoSim Labs, Inc. (VIVS) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AMD carries a Unified Composite Score of 46.7/100 (HOLD) at $489.19 (27.3x Forward P/E, 17.8% operating margin), whereas VIVS carries 36.8/100 (SELL) at $0.29 (N/M Forward P/E, -10117.0% operating margin).
Technical & Structure Timing Caution: AMD trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 45.2); meanwhile VIVS is in a Breakdown options structure phase (RSI 75.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Biotechnology value chain with $2.4M market capitalization and -10117.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ AMD vs VIVS Key Questions & Quantitative Answers
As of Nov 19, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over VivoSim Labs, Inc. (VIVS) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AMD carries a Unified Composite Score of 46.7/100 (HOLD) at $489.19 (27.3x Forward P/E, 17.8% operating margin), whereas VIVS carries 36.8/100 (SELL) at $0.29 (N/M Forward P/E, -10117.0% operating margin). Technical & Structure Timing Caution: AMD trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 45.2); meanwhile VIVS is in a Breakdown options structure phase (RSI 75.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
AMD leads the Growth & Scale pillar: AMD posts +44.7% YoY revenue growth and +93.8% YoY earnings growth on $45.4B TTM revenue (56.0% gross margin, 17.8% operating margin), compared with VIVS at -51.4% YoY revenue growth and +0.0% YoY earnings growth on $112,000 TTM revenue (N/A gross margin, -10117.0% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), AMD cumulative revenue shifted +414.7% while VIVS shifted N/A. In operating R&D and SG&A reinvestment, AMD deploys 38.2% of Rev ($17.4B) (7 90-day corporate R&D disclosures) versus N/A (0 disclosures) for VIVS.
AMD screens cheaper on headline valuation multiples. AMD trades at 27.3x Forward P/E, 113.3x Trailing P/E, 0.45x PEG, and 19.3x EV/Revenue (15.5% FCF margin), whereas VIVS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 9.6x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AMD (12.0% ROE) versus VIVS (-343.1% ROE) capital efficiency.
In options market volatility and institutional positioning, AMD carries 128.2% implied volatility (17th %ile, Compressed (<25th %ile)), a 1.08x (Balanced) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (3.61β · 120% Vol realized risk). By comparison, VIVS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (0.83β · 480% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.